Cao Y, Qu HJ, Li P et al (2011) Single dose administration of L-carnitine improves antioxidant activities in healthy subjects
doi: 10.1016/j.jhep.2015.04.006
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
GLP-1 medications may cause side effects including but not limited to nausea, vomiting, diarrhea, constipation, abdominal pain, headache, fatigue, and potential serious complications
The pharmacy must be licensed in your state to legally ship medication there